Evidence map›Paper›PMID 42389531›Full record

ArticleFrontiers in immunology2026

Huan Zhang, Xueyu Tao, Yuanzhi Wang, Yueli Wang, Huilin Hou, Xiaoyu Deng, Zhenyu Xu, Xujin Xia, Mingguo Xu, Zhen Wang and 6 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Huan Zhang *School of Animal Science and Technology, Shihezi University, Xinjiang, China.
Xueyu Tao *School of Animal Science and Technology, Shihezi University, Xinjiang, China.
Yuanzhi Wang *School of Medicine, Shihezi University, Xinjiang, China.
Yueli WangSchool of Medicine, Shihezi University, Xinjiang, China.
Huilin HouSchool of Animal Science and Technology, Shihezi University, Xinjiang, China.
Xiaoyu DengSchool of Animal Science and Technology, Shihezi University, Xinjiang, China.
Zhenyu XuSchool of Animal Science and Technology, Shihezi University, Xinjiang, China.
Xujin XiaCenter for Animal Disease Control and Diagnosis in Bayinggolin Mongol Autonomus Prefecture, Xinjiang, China.
Mingguo XuSchool of Animal Science and Technology, Shihezi University, Xinjiang, China.
Zhen WangSchool of Animal Science and Technology, Shihezi University, Xinjiang, China.
Changsuo ZhangTecon Biological Co. Ltd., Urumqi, China.
Zhumanov Kairat ToksanbaevichSchool of Animal Science and Technology, Kazakh National Agrarian University, Almaty, Kazakhstan.
Jinliang ShengSchool of Animal Science and Technology, Shihezi University, Xinjiang, China.
Zhongchen MaSchool of Animal Science and Technology, Shihezi University, Xinjiang, China.
Jihai YiSchool of Animal Science and Technology, Shihezi University, Xinjiang, China.
Chuangfu ChenSchool of Animal Science and Technology, Shihezi University, Xinjiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IL-10, an anti-inflammatory cytokine, plays a crucial role in limiting immune responses to pathogens, preventing host damage. However, the mechanisms underlying

Indexed as

Bacterial ProteinsBrucella melitensisBrucellosisInterleukin-10MAP Kinase Kinase KinasesProto-Oncogene ProteinsAnimalsChronic DiseaseFemaleMacrophagesMiceBacterial ProteinsIL10 protein, mouseInterleukin-10Map3k8 protein, mouseMAP Kinase Kinase KinasesProto-Oncogene ProteinsBrucella melitensis M5-90IL-10proline racemasetumor progression locus 2vaccine

Identifiers

PMID42389531
PMCPMC13320626

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.